Ozempic, Wegovy and Life Insurance: How GLP-1 Drugs Affect Your Rates in 2026

If you take Ozempic, Wegovy, Mounjaro, Zepbound, or another GLP-1 medication, you are far from alone. Gallup found that 11% of U.S. adults were using one for weight loss in June 2026, up from 3% in 2024. Awareness has reached 91%.

That rapid growth has created a practical insurance question: does taking a GLP-1 help your life insurance application because your health is improving, or hurt it because the prescription points to an underlying condition?

The honest answer is that it can do either, and the medication name by itself does not decide the outcome. Underwriters look at why it was prescribed, how long you have taken it, whether treatment has been consistent, how your health measurements are changing, and whether those changes appear stable.

The Short Answer

Taking a GLP-1 is not an automatic decline for life insurance. It does not automatically earn a preferred rate either.

An insurer is trying to estimate long-term risk over a policy that may last 10, 20, or 30 years. A current weight and one prescription fill provide only a snapshot. The underwriter wants the story around that snapshot.

Someone taking semaglutide for well-controlled type 2 diabetes may present a different risk from someone who started it for weight management six weeks ago. A person with regular follow-up, stable lab results, and consistent prescription fills may be viewed differently from someone whose medical record does not make the diagnosis clear.

Why This Became a 2026 Insurance Issue

GLP-1 drugs have treated type 2 diabetes for years, but newer approvals and weight-management use changed the scale of the conversation.

Ozempic is a semaglutide product approved for type 2 diabetes. Wegovy uses semaglutide for chronic weight management and certain other approved indications. Mounjaro contains tirzepatide for type 2 diabetes, while Zepbound uses tirzepatide for chronic weight management and other approved uses.

Gallup's May 28 to June 5, 2026 survey of 5,065 adults found that current use for weight loss had risen to 11%, nearly four times the 2024 share. Milliman IntelliScript, which analyzes prescription information used in insurance underwriting, reports that GLP-1 incidence in prescription histories has increased more than fivefold since 2020. More than 11% of its Irix Prescription Data hits now show at least one GLP-1.

In other words, this is no longer an unusual medication that underwriters see occasionally. It is part of routine risk assessment.

What the Insurance Company Can Review

Traditional life insurance underwriting usually begins with your application and health questions. With your authorization, the insurer may also use several outside sources:

• Prescription history showing the medication, dose, fill pattern, and other drugs that provide medical context
• Medical claims or electronic health records showing diagnoses, appointments, and treatment history
• Lab results such as A1c, fasting glucose, cholesterol, liver values, and kidney function
• Your height and weight history, including recent gains or losses
• An attending physician statement when the available data does not answer the underwriter's questions
• A medical exam, depending on the policy amount, applicant, and underwriting path

Your authorization is part of the application process. The insurer should disclose the types of information it may obtain. Answer every medication and health question accurately, even if a drug was prescribed online or through a telehealth service.

A no-medical-exam life insurance application may skip the nurse visit, blood draw, or urine sample. It does not necessarily skip prescription records, claims data, electronic health information, or database checks.

Why the Reason for the Prescription Matters

A GLP-1 medication is not a diagnosis. The same class is used in very different medical situations, including type 2 diabetes, chronic weight management, cardiovascular risk reduction, obstructive sleep apnea, chronic kidney disease, and metabolic liver disease.

Milliman's 2026 clinical guidance tells underwriters to confirm the condition rather than treat the prescription as a shortcut. That context can change the entire review.

For an applicant with diabetes, the underwriter may focus on:

• A1c and fasting glucose
• How long diabetes has been diagnosed
• Kidney, eye, nerve, and cardiovascular complications
• Blood pressure and cholesterol
• Whether prescriptions and follow-up have been consistent

For an applicant using a GLP-1 primarily for weight management, the review may focus more on:

• Starting and current weight
• How quickly the weight changed
• How long the current weight has been stable
• Whether the medication is still being taken consistently
• Related conditions such as sleep apnea, hypertension, fatty liver disease, or joint problems
• The care plan if the medication is stopped or changed

Long-term, consistent treatment can sometimes be a positive sign, especially when the underlying condition is controlled. A prescription with no clear diagnosis or follow-up can create more questions.

The Recent Weight-Loss Rule

Life insurers have long treated rapid, recent weight loss cautiously, even when no medication is involved. The concern is not that losing weight is unhealthy. The concern is that a lower weight may be temporary, caused by an unresolved illness, or too recent to represent the risk over a long policy term.

Many carriers want roughly 12 months of stability before giving full credit for a large loss. Until then, an underwriter may add back part of the weight for the purpose of the build chart. A commonly used approach is to add back half of the weight lost during the prior year.

For example, someone who recently lost 40 pounds might be assessed as if 20 pounds were added to the current weight. That is an illustration, not a universal formula. Each carrier sets its own rules, and the amount, timing, cause, and medical records all matter.

This can be frustrating when your blood pressure, mobility, glucose, or other measurements have clearly improved. It does not mean the insurer is ignoring that progress. It means the company is deciding how much of a recent change it can use when pricing coverage for decades.

What Can Help an Application

Underwriting tends to go more smoothly when the record tells one consistent story. Helpful factors can include:

• A clearly documented reason for the medication
• Regular prescription fills over a meaningful period
• Stable use rather than repeated starts and stops
• Follow-up visits with the prescribing clinician
• Improved or well-controlled A1c, blood pressure, cholesterol, and other relevant measurements
• A stable weight for about a year after a substantial loss
• Appropriate treatment of related conditions, such as CPAP use for sleep apnea
• No unexplained gaps between what the application says and what the records show

None of these promises a particular rate class. Age, tobacco use, family history, driving record, other health conditions, policy size, and the carrier's guidelines still count.

What May Lead to More Questions

An underwriter may need more records, postpone a decision, or offer a higher rate when:

• The medication was started recently and the response is not yet clear
• Prescription fills are intermittent
• Weight is still changing quickly
• The underlying diagnosis is unclear
• Diabetes or another condition is not well controlled
• Follow-up care is missing
• The application omits a prescription that appears in the database
• Side effects or another medical issue have caused treatment changes

Cost can affect consistency. A KFF survey conducted in late 2025 found that 56% of current GLP-1 users said the drugs were difficult to afford. That does not tell an insurer what any one applicant will do, but it helps explain why underwriters pay attention to refill patterns and continuity.

Do not change or stop a medication to improve an insurance application. That decision belongs between you and the clinician treating you. Interrupting appropriate care can harm your health, and an unexplained stop may create more underwriting uncertainty rather than less.

Are Insurers Starting to View GLP-1s More Favorably?

The industry's understanding is changing as the evidence grows.

In February 2026, Munich Re published a large study using de-identified medical and prescription data representing 41 million lives. It found favorable mortality patterns among GLP-1 users and estimated that these therapies may support annual mortality improvement of 0.2% to 0.5%, realized over a 20-year period.

That is a population-level forecast for insurers. It is not a 0.5% discount on your premium, and it does not mean every GLP-1 user has the same outcome. Munich Re also emphasized that adherence, individual response, diagnosis, and electronic health records are essential to understanding the risk.

The direction is still meaningful. Insurers that once saw only a diagnosis or a build measurement can now see evidence of active treatment and improving metabolic health. Carrier guidelines will not all change at the same speed, which makes comparison especially important.

Should You Apply Now or Wait?

Do not leave your family unprotected solely to chase a better rate class later. If you need life insurance now, applying now gives you a real decision and a real price to evaluate.

There are situations where more time and stability may improve the result. If you just started treatment, recently lost substantial weight, or are waiting on follow-up labs, ask an experienced independent agent how different carriers are likely to view the timing. The answer may be to apply now, wait briefly for a scheduled record, or approach a carrier with guidelines that fit your history better.

If you accept coverage now and your health later shows sustained improvement, ask whether the insurer allows a rate reconsideration. You can also compare replacement coverage later, but never cancel an existing policy until a new one is approved, accepted, paid, and in force.

The right policy type and amount still matter more than optimizing one underwriting detail. A straightforward term life policy may cover the years your family depends on your income. Our guide to calculating how much life insurance you need can help you set the target before you compare rates.

How to Prepare Before Applying

You do not need to build a medical file for the insurer, but having accurate details can prevent delays:

• List the exact medication, dose, start date, prescribing clinician, and reason it was prescribed
• Know your approximate starting weight, current weight, and when the change occurred
• Gather recent A1c, blood pressure, cholesterol, or other relevant results if you have them
• Be ready to explain any gaps or changes in treatment
• Make sure related conditions and treatments are accurately listed
• Ask whether the quote assumes a final rate class or is only an initial estimate
• Compare carriers, because underwriting treatment can differ even when the health facts are identical

Want help thinking through the application before you submit it? Chat with Julia, our life insurance specialist. She can help you organize the questions to ask, compare coverage types, and understand what may affect the rate, all in a free conversation.